HomeWashington Letter2014 ▶ VA Appoints O’Leary for CRADO Role
VA Appoints O’Leary for CRADO Role

June 2014

This week, the VA announced the appointment of Timothy J. O'Leary, MD, PhD, as chief research and development officer (CRADO) for VA, effective June 2014. He had been serving as acting CRADO since June 2013.

As CRADO, O'Leary will oversee a nationwide research program based at more than 100 VA medical centers that addresses the full range of health concerns affecting America's Veterans, from post-deployment health to chronic diseases and aging. The program, dating back to 1925, includes biomedical, clinical, rehabilitation, and health services research. It has resulted in three Nobel prizes, seven Lasker awards, and numerous other national and international honors for its investigators.

O'Leary holds a doctorate in physical chemistry from Stanford University and a medical degree from the University of Michigan. He is certified in anatomic pathology by the American Board of Pathology and in molecular genetic pathology by the American Board of Pathology and the American Board of Medical Genetics.

His own research interests include genomics, proteomics, and ultrasensitive detection of biological toxins. He has served on numerous federal panels and advisory committees, including the Health and Human Services Clinical Laboratory Improvement Advisory Committee and the Food and Drug Administration Hematology and Devices Panel.

O'Leary, the holder of three patents, has authored or co-authored more than 170 journal articles and numerous book chapters and technical reports. He is a past president of the Association for Molecular Pathology and serves as editor-in-chief for its Journal of Molecular Diagnostics.

Last Reviewed: October 2017